Innoviva, Inc. (INVA): Price and Financial Metrics

INVA POWR Grades

• INVA scores best on the Value dimension, with a Value rank ahead of 97.84% of US stocks.
• The strongest trend for INVA is in Quality, which has been heading up over the past 179 days.
• INVA ranks lowest in Sentiment; there it ranks in the 10th percentile.

INVA Stock Summary

• With a price/earnings ratio of 3.02, INNOVIVA INC P/E ratio is greater than that of about just 3.94% of stocks in our set with positive earnings.
• Of note is the ratio of INNOVIVA INC's sales and general administrative expense to its total operating expenses; just 0.31% of US stocks have a lower such ratio.
• For INVA, its debt to operating expenses ratio is greater than that reported by just 0.35% of US equities we're observing.
• If you're looking for stocks that are quantitatively similar to INNOVIVA INC, a group of peers worth examining would be CRK, EQT, CPG, WPM, and PXS.
• INVA's SEC filings can be seen here. And to visit INNOVIVA INC's official web site, go to www.inva.com.

INVA Valuation Summary

• INVA's price/sales ratio is 2.3; this is 54.9% lower than that of the median Healthcare stock.
• Over the past 223 months, INVA's price/sales ratio has gone down 125.1.

Below are key valuation metrics over time for INVA.

INVA Growth Metrics

The year over year net income to common stockholders growth rate now stands at -25.91%.
• Its 2 year cash and equivalents growth rate is now at -38.41%.
• Its 5 year cash and equivalents growth rate is now at 120.25%.

Over the past 33 months, INVA's revenue has gone up $112,200,000.

The table below shows INVA's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	373.216	291.208	292.58
2022-06-30	403.821	372.229	99.495
2022-03-31	396.407	377.808	187.504
2021-12-31	391.866	363.813	265.854
2021-12-31	391.866	363.813	265.854
2021-09-30	374.662	350.712	309.412

INVA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• INVA has a Quality Grade of B, ranking ahead of 77.13% of graded US stocks.
• INVA's asset turnover comes in at 0.398 -- ranking 118th of 682 Pharmaceutical Products stocks.
• LUMO, RETA, and SUPN are the stocks whose asset turnover ratios are most correlated with INVA.

The table below shows INVA's key quality metrics over time.